CA
NZ
UK
AU
IND
US
LiveWire Group (NYSE: LVWR)jumped47.80%to$2.35, a sharp rebound move for the electric motorcycle maker. The rally appears linked to renewed attention on operating improvements and a reset in expectations following updated financial results.
Indirect negotiations between the United States and Iran have resumed in Geneva, reflecting renewed efforts to stabilise one of the most persistent flashpoints in global geopolitics. The discussions, mediated by Oman, focus primarily on Iran’s nuclear programme and the potential lifting of US sanctions.
Celsius Holdings Inc. delivered fourth-quarter 2025 results that exceeded consensus forecasts on both revenue and earnings, underscoring operational momentum in the competitive U.S. energy drink market.
NVIDIA Corporation reported fourth-quarter fiscal 2026 results that exceeded consensus expectations on both revenue and earnings per share. Diluted EPS came in at USD 1.62 versus expectations of USD 1.52, while revenue reached USD 68.1 billion compared with estimates of USD 65.56 billion.
Market Movers:On Wednesday, the top gainers were Braiin Limited (+79.35%), followed by Larimar Therapeutics, Inc. (+61.25%). On the contrary, ODDITY Tech Ltd. (-49.21%), and MannKind Corporation (-36.82%) declined the most the same day.
Shares ofIonQ Inc.climbed more than 12% in pre-market trading after the company reported triple-digit revenue growth and issued stronger-than-expected 2026 guidance. The results triggered a broader rally across quantum computing equities, lifting peers such asRigetti Computing Inc.,D-Wave Quantum Inc., andQuantum Computing Inc..
Clear Secure Inc (NYSE:YOU) surged 38.54% to $46.37 (February 25, 2026), signaling renewed investor confidence in the biometric identity verification company.
Sigma Lithium Resources Corp (NASDAQ:SGML) gained 29.92% to $16.37 amid renewed optimism in lithium markets.
Nutanix Inc (NASDAQ:NTNX) surged 29.77% to $49.13, driven by strong investor reaction to business momentum.
NRx Pharmaceuticals Inc (NASDAQ:NRXPW) jumped 44.97% to $0.05 (February 25, 2026), making it one of the top percentage gainers among US-listed stocks. The sharp move has drawn attention from speculative biotech investors looking for high-risk, high-reward opportunities.
Please wait processing your request...